» Articles » PMID: 38352408

Mice Born Preterm Develop Gait Dystonia and Reduced Cortical Parvalbumin Immunoreactivity

Overview
Journal bioRxiv
Date 2024 Feb 14
PMID 38352408
Authors
Affiliations
Soon will be listed here.
Abstract

Preterm birth leading to cerebral palsy (CP) is the most common cause of childhood dystonia, a movement disorder that is debilitating and often treatment refractory. Dystonia has been typically associated with dysfunction of striatal cholinergic interneurons, but clinical imaging data suggests that cortical injury may best predict dystonia following preterm birth. Furthermore, abnormal sensorimotor cortex inhibition has been found in many studies of non-CP dystonias. To assess the potential for a cortical etiology of dystonia following preterm birth, we developed a new model of preterm birth in mice. Noting that term delivery in mice on a C57BL/6J background is embryonic day 19.1 (E19.1), we induced preterm birth at the limits of pup viability at embryonic day (E) 18.3, equivalent to human 22 weeks gestation. Mice born preterm demonstrate display clinically validated metrics of dystonia during gait (leg adduction amplitude and variability) and also demonstrate reduced parvalbumin immunoreactivity in the sensorimotor cortex, suggesting dysfunction of cortical parvalbumin-positive inhibitory interneurons. Notably, reduced parvalbumin immunoreactivity or changes in parvalbumin-positive neuronal number were not observed in the striatum. These data support the association between cortical dysfunction and dystonia following preterm birth. We propose that our mouse model of preterm birth can be used to study this association and potentially also study other sequelae of extreme prematurity.

References
1.
Aravamuthan B, Pearson T, Chintalapati K, Ueda K . Under-recognition of leg dystonia in people with cerebral palsy. Ann Child Neurol Soc. 2024; 1(2):162-167. PMC: 10923506. DOI: 10.1002/cns3.20018. View

2.
Eskow Jaunarajs K, Bonsi P, Chesselet M, Standaert D, Pisani A . Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog Neurobiol. 2015; 127-128:91-107. PMC: 4420693. DOI: 10.1016/j.pneurobio.2015.02.002. View

3.
Clancy B, Finlay B, Darlington R, Anand K . Extrapolating brain development from experimental species to humans. Neurotoxicology. 2007; 28(5):931-7. PMC: 2077812. DOI: 10.1016/j.neuro.2007.01.014. View

4.
Tassone A, Sciamanna G, Bonsi P, Martella G, Pisani A . Experimental models of dystonia. Int Rev Neurobiol. 2011; 98:551-72. DOI: 10.1016/B978-0-12-381328-2.00020-1. View

5.
Dos Santos Rufino A, Pahlman M, Olsson I, Himmelmann K . Characteristics and Challenges of Epilepsy in Children with Cerebral Palsy-A Population-Based Study. J Clin Med. 2023; 12(1). PMC: 9821172. DOI: 10.3390/jcm12010346. View